Company intelligence / Profile preview

MediPines

Orange County, California, United States

Ownership: Private
Development stage: Other

Overview

MediPines' AGM100 is FDA-cleared and in clinical use in North America, providing real-time, non-invasive cardiorespiratory assessment, including for patients with COVID-19 symptomatology and hypoxemia. The device has also been tested at academic centers and recognized by the WHO and pediatric device innovation awards.[1][3][2]

Therapeutic areas: Infectious DiseasesPulmonologyCardiovascular
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on MediPines.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediPines.

Explore the full profile